chevron_leftBack
As of 14 June 2026, Inspire Medical Systems, Inc. has a market cap of $1.54B USD, ranking #8326 globally and #1876 in the United States.
It ranks #699 in the Healthcare sector, and #136 in the Medical Devices industry.
Key Stats
Market Cap
$1.54BUSD
Enterprise Value
$1.26BUSD
Revenue (TTM)
$911.98MUSD
EBITDA (TTM)
$64.91MUSD
Net Income (TTM)
$145.42MUSD
EBITDA Margin
7.1%
Profit Margin
16%
PE Ratio
10.9
Forward PE
26.3
PS Ratio
1.7
PB Ratio
2.0
EV/EBITDA
19.4
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Timothy Herbert
open_in_new
Employees
1,333
Founded
2007
IPO
03 May 2018
Website
inspiresleep.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -3.1% | -1.5% | 6.5% | -35% | -31% | -66% |
News
Loading...
INSP Analyst Forecasts
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
INSP
Inspire Medical Systems Inc
ISIN: US4577301090
Shares Out.:
Shares Outstanding:
28.813M1
Shares Float:
27.17M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
NQ:
NASDAQ:
BA:
Barron's:
MS:
Morningstar:
|
53.41 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Inspire Medical Systems, Inc.
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: TMO
|
$173.27B
11K%
|
25.8
|
|
NASDAQ: ISRG
|
$160.73B
10K%
|
56.7
|
|
NYSE: ABT
|
$159.07B
10K%
|
25.6
|
|
NYSE: DHR
|
$126.55B
8K%
|
34.7
|
|
NYSE: SYK
|
$120.69B
8K%
|
38.3
|
|
NYSE: BSX
|
$84.93B
5K%
|
24.5
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: MDT
|
$101.9B
7K%
|
22.2
|
|
EPA: EL
|
$97.46B
6K%
84.32B EUR
|
36.7
|
|
TSE: 7741
|
$61.41B
4K%
9.83T JPY
|
40.0
|
|
XETRA: SHL
|
$45.47B
3K%
39.34B EUR
|
18.7
|
|
SIX: ALC
|
$36.38B
2K%
28.99B CHF
|
37.9
|
|
|
$30.06B
2K%
203.66B CNY
|
26.0
|
chevron_leftBack